Workflow
医用敷料
icon
Search documents
稳健医疗上半年营收增长31.3%,全棉时代线下门店迎调整
21世纪经济报道记者雷若馨深圳报道 打着"医疗+消费"的牌,全棉时代母公司稳健医疗交出了一份不错的成绩单。 近日,稳健医疗(300888.SZ)发布半年报。2025年上半年,公司实现营收53亿元,同比增长31.3%;实 现归母净利润 4.9 亿元,同比增长28.1%;扣非归母净利润4.6亿元,同比增长40.9%。 稳健医疗前身创立于1991年,最初从医用敷料代工起步。2009年,稳健医疗创立消费品品牌"全棉时 代",其业务领域也逐渐从医疗延伸至消费品。今年上半年,医疗板块与消费板块分别为其贡献25.2亿 元、27.5亿元营收。 医疗板块回升 目前,其医疗板块以"稳健医疗"品牌为核心,主营医用敷料、口罩、手术室耗材。 2020年,因市场对口罩等疾控防护产品需求激增,稳健医疗的医疗板块营收暴涨616.5%至86.84亿元, 并在当年成功上市。随着公共卫生事件的影响减弱,其相关板块营收在高基数影响下出现大幅下滑。 过去两年,稳健医疗通过调整产品结构、去库存等方式逐渐平稳下滑趋势,恢复相关板块增长。 2025年上半年,稳健医疗的医疗板块营收为25.2亿元,同比增长46.4%。剔除并购公司GRI的贡献,实 现19.5亿 ...
奥美医疗(002950) - 002950奥美医疗投资者关系管理信息20250612
2025-06-12 10:48
Group 1: Financial Performance - The company has distributed a total cash dividend of approximately 1.099 billion yuan from 2018 to 2024, which is 2.29 times the net amount of funds raised [3][5] - In 2024, the company achieved overseas revenue of 2.756 billion yuan, a year-on-year increase of 23.43%, accounting for 82.87% of total revenue [3][4] - Domestic revenue reached 569.79 million yuan in 2024, up 8.86% year-on-year, representing 17.13% of total revenue [4] Group 2: Market Strategy - The company has implemented a dual-drive strategy focusing on both domestic and international markets to increase market share [5][6] - The company has maintained its position as the leading exporter in China's medical dressing industry for 17 consecutive years since 2008 [3][7] - Future focus areas include expanding product lines in surgical and wound care, infection prevention, advanced dressings, and hygiene care products [6][7] Group 3: Challenges and Outlook - The company acknowledges that stock price fluctuations are influenced by various factors, emphasizing the importance of long-term value creation for shareholders [5][6] - Recent reductions in cash dividends are attributed to strategic upgrades and planned investments in emerging markets and product development [6] - The company aims to enhance brand influence and market share in the domestic market through e-commerce and professional hospital channels [4][6]
专注医用敷料创新 颜本舒品牌升级暨新品发布会举行
Chang Sha Wan Bao· 2025-05-27 14:19
Group 1 - The core viewpoint of the article highlights the launch of the "Yuan Benshu" brand by Kefu Medical, focusing on innovative medical dressings and skin repair products to drive high-quality development in the industry [1][3] - Kefu Medical emphasizes that "Yuan Benshu" is not a face mask but a medical dressing, aiming to provide safer and more effective skin repair solutions based on nearly 20 years of medical research and development [3][5] - The brand's name "ibssom," meaning "to bloom," reflects a commitment to women's health and confidence, with a product matrix covering various application methods [5] Group 2 - Three innovative products were launched at the event: the upgraded "Little Blue Mask 3.0," a liquid collagen dressing, and the "White Ice Cannon" strong pulsed light therapy device [1][7] - The "Little Blue Mask 3.0" features an improved formulation with upgraded hyaluronic acid content and added natto essence, enhancing its moisturizing and repairing effects [5][7] - The liquid collagen dressing offers 100% human-derived collagen and utilizes advanced structural technology to improve skin elasticity and reduce signs of aging [7][9] Group 3 - The "White Ice Cannon" device combines medical equipment with medical dressings, showing significant clinical results, including a 94.31% reduction in hair density and a 26.28% decrease in skin roughness after four weeks of use [7][9] - Experts noted that the medical beauty market has surpassed 300 billion yuan, with increasing consumer demand for safe and effective skin repair products, positioning Yuan Benshu's new offerings as solutions to industry pain points [9]
89.78亿元!稳健医疗最新年报
思宇MedTech· 2025-04-29 09:55
正式报名:首届全球心血管大会 | 赠送纸质白皮书 合作伙伴征集:2025全球手术机器人大会 2025年4月29日, 稳健医疗 发布2024年年报。 # 财务数据 # 关 于 稳健医疗 稳健医疗用品股份有限公司成立于 2000 年 8 月 24 日,总部位于广东省深圳市龙华区,2020 年 9 月 17 日在 A 股上市。公司通过 "winner 稳健医疗" 和 "Purcotton 全棉时代" 两大品牌 营收与利润 : 2024 年实现营业收入 89.78 亿 元,同比增长 9.69% ;归母净利润 6.95 亿 元,同比增长 19.81%;扣非净利润同比大增 43.40%。 单季度数据 : 2024 年第四季度营业总收入 29.08 亿 元,同比增长 33.72% , 环比增长 42.78%;归母净 利润 1.42 亿元,同比增长 109.09%,环比下降 15.64%;扣非净利润 2.24 亿元,同比增长 207.02%,环 比增长 54.26%。 盈利能力 : 2024 年毛利率 47.32% ,同比下降 1.68 个百分点; 净利率 8.25%,较上年同期上升 0.57 个 百分点。从单季度指标来看, ...